Short Description:
CAS number： 42461-84-7
Molecular formula： C21H28F3N3O7
molecular weight：491.46
Chemical structure：
| Basic Information | |
| Product name | Flunixin meglumine |
| CAS No. | 42461-84-7 |
| Color | off-white |
| Grade | Feed Grade |
| form | solid |
| Shelf Life | 2 years |
| storage temp. | Room temp |
| Instruction for use | Support |
| Package | 25kg/drum |
Description
Flunixin meglumine is an organic compound with the molecular formula C14H11F3N2O2.C7H17NO5 and a molecular weight of 491.4581. It is a white powder.
Animal anti-inflammatory and analgesic drugs
This medicine is used for horses, which can alleviate inflammation and pain caused by muscle abnormalities, relieve internal colic in horses, and treat diarrhea, tremors, colitis, etc. in horses
Respiratory diseases, eye surgeries, etc.
Used for cows to treat respiratory diseases.
Used for dogs to treat arthritis, fever, diarrhea, tremors, eye infections, etc.
Used for pigs, treating diarrhea, etc.
Flunixin meglumine is a novel, nonsteroidal animal specific antipyretic and analgesic drug, belonging to the nicotinic acid derivative and an inhibitor of cyclooxygenase.
Application of product
In the United States, flunixin meglumine is approved for use in horses, cattle and swine; however, it is approved for use in dogs in other countries. The approved indications for its use in the horse are for the alleviation of inflammation and pain associated with musculoskeletal disorders and alleviation of visceral pain associated with colic. In cattle it is approved for the control of pyrexia associated with bovine respiratory disease and endotoxemia, and control of inflammation in endotoxemia. In swine, flunixin is approved for use to control pyrexia associated with swine respiratory disease.
Flunixin has been suggested for many other indications in various species, including: Horses: foal diarrheas, shock, colitis, respiratory disease, post-race treatment, and pre- and post ophthalmic and general surgery; Dogs: disk problems, arthritis, heat stroke, diarrhea, shock, ophthalmic inflammatory conditions, pre- and post ophthalmic and general surgery, and treatment of parvovirus infection; Cattle: acute respiratory disease, acute coliform mastitis with endotoxic shock, pain (downer cow), and calf diarrheas; Swine: agalactia/hypogalactia, lameness, and piglet diarrhea. It should be noted that the evidence supporting some of these indications is equivocal and flunixin may not be appropriate for every case.
